Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples